ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid interference (RNAi) technology. Its robust pipeline of RNAi-based treatments addresses a range of critical therapeutic areas, including inherited genetic disorders, cardio-metabolic conditions, hepatic infectious diseases, and central nervous system (CNS) and ocular disorders. Currently, Alnylam offers several approved therapies: ONPATTRO (patisiran) for adults suffering from polyneuropathy associated with hereditary transthyretin-mediated amyloidosis; GIVLAARI for adult patients with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for primary hyperoxaluria type 1 (PH1). Beyond its commercial portfolio, the company maintains an active development pipeline. Key investigational therapies include givosiran, aimed at adolescent patients with AHP; patisiran, being explored for transthyretin amyloidosis (ATTR) with cardiomyopathy; cemdisiran for complement-mediated disorders; ALN-AAT02 for AAT deficiency-associated liver disease; ALN-HBV02 for chronic hepatitis B virus infection; Zilebesiran for hypertension; and ALN-HSD for non-alcoholic steatohepatitis (NASH). Additionally, other candidates such as Fitusiran for hemophilia and bleeding disorders, Inclisiran for hypercholesterolemia, an expanded indication for lumasiran for advanced PH1 and recurrent kidney stones, and vutrisiran for ATTR amyloidosis (currently in Phase 3 clinical trials) are also progressing. Alnylam also engages in strategic alliances with other pharmaceutical leaders. Notable collaborations include those with Regeneron Pharmaceuticals, Inc., focused on discovering and developing RNAi therapeutics for ocular and CNS targets, and with Sanofi Genzyme for broader RNAi therapeutic development and commercialization efforts. Further licensing and partnership agreements are in place with entities such as Novartis AG, Vir Biotechnology, Inc., Dicerna Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., and PeptiDream, Inc. Established in 2002, Alnylam Pharmaceuticals maintains its corporate headquarters in Cambridge, Massachusetts.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNYHealthcare · Biotechnology
-5.17%$165.00
AH$165.88+0.53%vs close
Mkt Cap$22.1B
Float133.61M
O/S133.94M
Vol
$ Vol
RVOL
Inst Own99.1%
SI4.9%
Earnings
Dilution
Financials Summary
Revenue$3.71B
Net Income$313.75M
Total Assets$4.97B
Free Cash Flow$465.38M
Debt & Equity
Debt 62%
Equity 38%
Total Debt$1.28B
Total Equity$789.18M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ALNY's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$4.97B
Liabilities$4.18B
Accounts Receivable$777.57M
Accounts Payable$115.72M
Inventory$82.72M
PP&E (Net)$708.06M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 |
| Revenue | $3.71B | $2.25B | $1.83B | $1.04B | $844.29M | $492.85M | $219.75M | $74.91M | $89.91M | $47.16M | $41.1M | $50.56M | $47.17M | $66.72M | $82.76M | $100.04M | $100.53M | $96.16M | $50.9M | $26.93M | $5.72M | $4.28M | $176K | $0 |
| YoY Growth | 65.2% | 23.0% | 76.2% | 22.9% | 71.3% | 124.3% | 193.4% | -16.7% | 90.7% | 14.8% | -18.7% | 7.2% | -29.3% | -19.4% | -17.3% | -0.5% | 4.5% | 88.9% | 89.0% | 371.1% | 33.6% | 2330.7% | - | - |
| Cost of Revenue | $677.17M | $323.37M | $310.41M | $168.82M | $140.14M | $78.05M | $25.06M | $1.8M | $13.37M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $3.04B | $1.92B | $1.52B | $868.6M | $704.14M | $414.8M | $194.69M | $73.11M | $76.55M | $47.16M | $41.1M | $50.56M | $47.17M | $66.72M | $82.76M | $100.04M | $100.53M | $96.16M | $50.9M | $26.93M | $5.72M | $4.28M | $176K | $0 |
| Gross Margin | 81.8% | 85.6% | 83.0% | 83.7% | 83.4% | 84.2% | 88.6% | 97.6% | 85.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - |
| Research and Development | $1.32B | $1.13B | $1B | $883.01M | $792.16M | $654.82M | $655.11M | $505.42M | $390.63M | $382.39M | $276.5M | $190.25M | $112.96M | $86.57M | $99.3M | $106.38M | $108.73M | $96.88M | $120.69M | $49.8M | $35.32M | $24.6M | $13.1M | $3.34M |
| Selling, General, and Administrative | $1.21B | $975.53M | $795.65M | $770.66M | $620.64M | $588.42M | $479M | $382.36M | $199.37M | $89.35M | $60.61M | $44.53M | $27.15M | $44.61M | $38.28M | $37.73M | $39.91M | $27.11M | $23.39M | $16.63M | $13.87M | $11.94M | $7.53M | $880K |
| Other | $0 | $0 | $0 | $0 | -$2.05M | $0 | $0 | $4.17M | -$3.02M | $0 | $76K | $1.82M | -$47K | $331K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $2.54B | $2.1B | $1.8B | $1.65B | $1.41B | $1.24B | $1.13B | $887.78M | $590M | $471.75M | $337.11M | $234.78M | $140.11M | $131.18M | $137.57M | $144.11M | $148.64M | $124M | $144.07M | $66.43M | $49.19M | $36.54M | $20.62M | $4.22M |
| Operating Income (EBIT) | $501.58M | -$176.88M | -$282.18M | -$785.07M | -$708.65M | -$828.44M | -$939.43M | -$814.67M | -$500.09M | -$424.59M | -$296.01M | -$404.98M | -$92.94M | -$129.46M | -$54.82M | -$44.07M | -$48.11M | -$27.84M | -$93.18M | -$39.5M | -$43.47M | -$32.26M | -$25.06M | -$4.22M |
| Operating Margin | 13.5% | -7.9% | -15.4% | -75.7% | -83.9% | -168.1% | -427.5% | -1087.6% | -556.2% | -900.3% | -720.3% | -801.0% | -197.0% | -194.0% | -66.2% | -44.1% | -47.9% | -28.9% | -183.1% | -146.7% | -760.5% | -754.2% | -14236.9% | - |
| Interest Expense | $252.63M | $141.86M | $121.22M | $155.97M | $143.02M | $84.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $872K | $1.08M | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $111.47M | $121.99M | $95.56M | $24.81M | $1.58M | $11.81M | $33.45M | $29.26M | $12.24M | $8.31M | $5.86M | $2.56M | $1.07M | $977K | $1.21M | $2.31M | $5.38M | $14.41M | $15.39M | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$178.43M | -$200.49M | -$151.34M | -$341.92M | -$143.49M | -$27.16M | $54.18M | $54M | $9.21M | $14.48M | $5.93M | $4.38M | $1.02M | $12.87M | -$2.83M | $1.07M | $1.1M | $2.31M | $12.96M | $4.89M | $558K | -$390K | -$4.64M | $0 |
| Income Before Tax (EBT) | $323.15M | -$377.38M | -$433.52M | -$1.13B | -$852.14M | -$855.6M | -$885.25M | -$760.67M | -$490.87M | -$410.11M | -$290.07M | -$400.6M | -$91.92M | -$116.59M | -$57.65M | -$43M | -$47.01M | -$25.53M | -$80.22M | -$34.61M | -$42.91M | -$35.37M | -$29.69M | $0 |
| Income Tax Expense | $9.4M | -$99.22M | $6.72M | $4.16M | $680K | $2.68M | $863K | $823K | $0 | $0 | $0 | -$40.21M | -$2.69M | -$10.57M | $0 | $514K | $582K | $719K | $5.25M | $0 | $0 | $390K | -$4.58M | -$86K |
| Net Income | $313.75M | -$278.16M | -$440.24M | -$1.13B | -$852.82M | -$858.28M | -$886.12M | -$761.5M | -$490.87M | -$410.11M | -$290.07M | -$360.39M | -$89.22M | -$106.01M | -$57.65M | -$43.52M | -$47.59M | -$26.25M | -$85.47M | -$34.61M | -$42.91M | -$32.65M | -$25.03M | -$4.14M |
| Net Income Margin | 8.4% | -12.4% | -24.1% | -109.0% | -101.0% | -174.1% | -403.2% | -1016.6% | -545.9% | -869.6% | -705.8% | -712.8% | -189.2% | -158.9% | -69.7% | -43.5% | -47.3% | -27.3% | -167.9% | -128.5% | -750.8% | -763.3% | -14223.3% | - |
| Supplementary Data | ||||||||||||||||||||||||
| EPS | 2.39 | -2.18 | -3.52 | -9.30 | -7.20 | -7.46 | -8.11 | -7.57 | -5.42 | -4.79 | -3.45 | -4.85 | -1.45 | -2.11 | -1.36 | -1.04 | -1.14 | -0.64 | -2.21 | -1.09 | -1.96 | -2.75 | -26.56 | -12.48 |
| Diluted EPS | 2.33 | -2.18 | -3.52 | -9.30 | -7.20 | -7.46 | -8.11 | -7.57 | -5.42 | -4.79 | -3.45 | -4.85 | -1.45 | -2.11 | -1.36 | -1.04 | -1.14 | -0.64 | -2.21 | -1.09 | -1.96 | -2.75 | -26.56 | -12.48 |
| Weighted Average OS | 131.00M | 127.65M | 124.91M | 121.69M | 118.45M | 114.99M | 109.26M | 100.59M | 90.55M | 85.60M | 83.99M | 74.28M | 61.55M | 50.29M | 42.41M | 42.04M | 41.63M | 41.08M | 38.66M | 31.89M | 21.95M | 11.89M | 942,665 | 331,341 |
| EBITDA | $631.44M | -$178.85M | -$258.24M | -$926.56M | -$661.56M | -$696.67M | -$830.88M | -$754.24M | -$488.19M | -$409.46M | -$276.96M | -$172.29M | -$82.71M | -$51.71M | -$49.69M | -$38.06M | -$41.02M | -$18.93M | -$75.06M | -$35.69M | -$38.83M | -$29.55M | -$19.61M | -$4.19M |
| EBITDA Margin | 17.0% | -8.0% | -14.1% | -89.3% | -78.4% | -141.4% | -378.1% | -1006.9% | -543.0% | -868.2% | -673.9% | -340.8% | -175.4% | -77.5% | -60.0% | -38.0% | -40.8% | -19.7% | -147.5% | -132.5% | -679.3% | -690.7% | -11142.0% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 |
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash and Cash Equivalents | $1.66B | $966.43M | $812.69M | $866.39M | $819.98M | $496.58M | $547.18M | $420.15M | $645.36M | $193.62M | $180.9M | $75.18M | $53.17M | $51.41M | $70.23M | $74.6M | $137.47M | $191.79M | $105.16M | $127.95M | $15.76M | $20.27M | $23.19M | $15.48M |
| Short-Term Investments | $1.25B | $1.73B | $1.63B | $1.33B | $1.62B | $1.38B | $988.98M | $664.01M | $1.05B | $433.18M | $899.64M | $621.51M | $192.7M | $71.41M | $76.17M | $158.53M | $143.93M | $238.6M | $284.79M | $89.31M | $64.25M | $25.77M | $0 | $0 |
| Cash and Short-Term Investments | $2.91B | $2.69B | $2.44B | $2.19B | $2.44B | $1.87B | $1.54B | $1.08B | $1.69B | $626.8M | $1.08B | $696.69M | $245.87M | $122.81M | $146.4M | $233.13M | $281.4M | $430.39M | $389.95M | $217.26M | $80M | $46.05M | $23.19M | $15.48M |
| Accounts Receivable | $777.57M | $405.31M | $327.79M | $237.96M | $198.57M | $602.41M | $43.01M | $18.76M | $34M | $23.33M | $8.3M | $39.94M | $4.25M | $104K | $1.47M | $3.45M | $6.04M | $4.19M | $5.03M | $3.83M | $755K | $1.17M | $0 | $0 |
| Inventory | $82.72M | $78.51M | $89.15M | $128.96M | $86.36M | $75.2M | $56.35M | $24.07M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$226.24M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $281.89M | $116.96M | $126.38M | $132.92M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.91M | $0 | $0 | $0 | $1.94M | $3.87M | $0 | $0 | $0 | $0 | $373K | $19K |
| Total Current Assets | $4.05B | $3.3B | $2.98B | $2.69B | $2.81B | $2.61B | $1.72B | $1.2B | $1.76B | $671.88M | $1.11B | $746.37M | $254.03M | $125.56M | $152.03M | $254.14M | $293.53M | $443.12M | $397.9M | $222.78M | $82.41M | $48.18M | $24.19M | $15.52M |
| Long-Term Assets | ||||||||||||||||||||||||
| Property, Plant & Equipment Net | $708.06M | $693.93M | $725.79M | $738.63M | $733.63M | $706.51M | $646.38M | $320.66M | $181.9M | $114.57M | $27.81M | $21.74M | $16.45M | $19.8M | $14.64M | $18.29M | $18.32M | $19.19M | $13.81M | $12.17M | $10.58M | $11.69M | $4.76M | $526K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $275K | $448K | $622K | $795K | $968K | $1.93M | $2.49M | $3.4M | $3.88M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $14.82M | $44.83M | $13.92M | $324.8M | $251.84M | $279.82M | $150.05M | $142.16M | $114.41M | $120.39M | $160.35M | $83.9M | $74.78M | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $125.97M | $116.86M | $10.1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $31.67M | $0 | $0 | $0 | $0 | $8.56M | $4.51M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $81.63M | $133.9M | $111.29M | $115.48M | $101.09M | $85.77M | $18.07M | $8.62M | $34.17M | $151.56M | $1.47M | $0 | $0 | $0 | $564K | $0 | $0 | $3.15M | $6.33M | $3.12M | $2.86M | $2.83M | $2.36M | $66K |
| Total Long-Term Assets | $915.67M | $944.7M | $847.18M | $854.11M | $834.73M | $792.28M | $679.27M | $374.11M | $229.99M | $590.93M | $281.12M | $333.23M | $166.5M | $161.96M | $129.89M | $139.13M | $187.85M | $111.55M | $95.89M | $17.22M | $15.93M | $17.93M | $10.99M | $592K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $4.97B | $4.24B | $3.83B | $3.55B | $3.64B | $3.41B | $2.4B | $1.57B | $1.99B | $1.26B | $1.39B | $1.08B | $420.53M | $287.52M | $281.92M | $393.26M | $481.38M | $554.68M | $493.79M | $240.01M | $98.35M | $66.11M | $35.18M | $16.11M |
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payable | $115.72M | $88.42M | $55.52M | $98.09M | $73.43M | $51.97M | $49.88M | $59.71M | $28.36M | $54.47M | $16.79M | $15.11M | $5.9M | $4.42M | $5.8M | $9.31M | $12.49M | $2.59M | $3.83M | $4.08M | $1.98M | $910K | $1.51M | $674K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.79M | $3.22M | $1.88M | $790K | $558K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.64M | $6.11M | $3.5M | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $4.84M | $55.48M | $102.75M | $42.1M | $149.48M | $127.21M | $77.82M | $3.5M | $41.7M | $33.54M | $15.35M | $23.87M | $32.7M | $31.42M | $62.37M | $81.62M | $82.77M | $79.86M | $59.25M | $11.14M | $10.73M | $1M | $333K | $0 |
| Other Current Liabilities | $477.26M | $421.2M | $177.16M | $170.98M | $130.66M | $110.75M | $68.3M | $40.87M | $35.81M | $15.27M | $12.32M | $40.03M | $5.93M | $950K | $484K | $0 | $0 | $1.56M | $1.39M | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $1.47B | $1.19B | $967.79M | $767.91M | $695.71M | $585.27M | $352.59M | $179.49M | $144.25M | $131.7M | $62.1M | $95.33M | $53.86M | $48.34M | $80.99M | $102.05M | $110.73M | $99.45M | $83.48M | $22.93M | $18.48M | $6.58M | $3.84M | $2.67M |
| Long-Term Liabilities | ||||||||||||||||||||||||
| Long-Term Debt | $1.01B | $1.02B | $1.02B | $1.02B | $675.7M | $191.28M | $0 | $30M | $30M | $150M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.96M | $5.92M | $5.52M | $6.41M | $1.3M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $188.18M | $193.79M | $152.36M | $225.09M | $318.38M | $458K | $43.08M | $49.39M | $52.97M | $42.98M | $93.39M | $100.87M | $78.49M | $129.97M | $189.88M | $250.12M | $204.07M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.48B | $1.73B | $1.63B | $1.46B | $1.25B | $1.1B | $9.33M | $62.88M | $10.97M | $11.5M | $6.73M | $5.01M | $2.92M | $4.25M | $4.44M | $3.01M | $2.8M | $2.98M | $4.12M | $9.99M | $12.57M | $6.98M | $56.74M | $18.08M |
| Total Long-Term Liabilities | $2.71B | $2.99B | $3.08B | $2.94B | $2.36B | $1.81B | $603.85M | $93.34M | $84.05M | $210.89M | $59.7M | $47.99M | $96.32M | $105.12M | $82.93M | $132.99M | $192.69M | $253.1M | $211.15M | $15.91M | $18.09M | $13.39M | $58.05M | $18.08M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$59.7M | -$47.99M | -$96.32M | -$105.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.18B | $4.17B | $4.05B | $3.7B | $3.06B | $2.39B | $956.44M | $272.84M | $228.3M | $342.59M | $121.8M | $143.33M | $150.18M | $153.47M | $163.92M | $235.03M | $303.42M | $352.55M | $294.62M | $38.83M | $36.57M | $19.96M | $61.89M | $20.76M |
| Stockholders' Equity | ||||||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $66.11M | $0 | $0 |
| Common Stock | $1.32M | $1.29M | $1.26M | $1.24M | $1.2M | $1.16M | $1.12M | $1.01M | $997K | $859K | $851K | $772K | $637K | $525K | $427K | $423K | $418K | $414K | $408K | $371K | $267K | $208K | $0 | $0 |
| Retained Earnings | -$6.7B | -$7.29B | -$7.01B | -$6.57B | -$5.44B | -$4.59B | -$3.73B | -$2.84B | -$2.15B | -$1.66B | -$1.25B | -$956.63M | -$596.24M | -$507.01M | -$401M | -$343.35M | -$299.83M | -$252.24M | -$225.99M | -$140.53M | -$105.92M | -$63.01M | -$29.52M | -$4.49M |
| Comprehensive Income & Other | -$20.1M | -$34.52M | -$23.38M | -$44.65M | -$33.26M | -$43.62M | -$36.52M | -$33.21M | -$34.43M | -$33.44M | $4.37M | $48.76M | $19.72M | $15.66M | -$165K | $714K | $716K | $1.19M | $300K | $551K | -$2.6M | -$3.28M | -$4.61M | -$161K |
| Other Stockholders' Equity | $7.49B | $7.35B | $6.79B | $6.41B | $6.03B | $5.6B | $5.16B | $4.14B | $3.91B | $2.58B | $2.51B | $1.89B | $865.95M | $640.54M | $518.57M | $501.16M | $477.38M | $453.95M | $424.75M | $341.33M | $167.43M | $108.94M | $2.81M | -$161K |
| Total Equity | $789.18M | $67.09M | -$220.64M | -$158.22M | $588.2M | $1.02B | $1.44B | $1.3B | $1.77B | $920.22M | $1.26B | $936.27M | $270.35M | $134.05M | $118M | $158.23M | $177.97M | $202.13M | $199.17M | $201.17M | $61.78M | $46.14M | -$26.71M | -$4.65M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $4.97B | $4.24B | $3.83B | $3.55B | $3.64B | $3.41B | $2.4B | $1.57B | $1.99B | $1.26B | $1.39B | $1.08B | $420.53M | $287.52M | $281.92M | $393.26M | $481.38M | $554.68M | $493.79M | $240.01M | $98.35M | $66.11M | $35.18M | $16.11M |
| Supplementary Data | ||||||||||||||||||||||||
| Total Debt | $1.28B | $1.3B | $1.31B | $1.32B | $997.59M | $521.19M | $303.82M | $30M | $30M | $150M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.76M | $9.14M | $7.39M | $7.2M | $1.86M | $0 |
| Net Debt | -$378.86M | $329.62M | $492.7M | $453.85M | $177.62M | $24.61M | -$243.35M | -$390.15M | -$615.36M | -$43.62M | -$1.28B | -$881.93M | -$53.17M | -$51.41M | -$70.23M | -$74.6M | -$137.47M | -$191.79M | -$98.4M | -$118.82M | -$8.36M | -$13.07M | -$21.33M | -$15.48M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 |
| Operating Activities | ||||||||||||||||||||||||
| Net Income | $313.75M | -$278.16M | -$440.24M | -$1.13B | -$852.82M | -$858.28M | -$886.12M | -$761.5M | -$490.87M | -$410.11M | -$290.07M | -$360.39M | -$89.22M | -$106.01M | -$57.65M | -$43.52M | -$47.59M | -$26.25M | -$85.47M | -$34.61M | -$42.91M | -$32.65M | -$25.03M | -$4.14M |
| Depreciation & Amortization | $55.66M | $56.67M | $54.05M | $44.47M | $47.57M | $74.44M | $54.37M | $6.43M | $13.37M | $15.13M | $19.05M | $11.93M | $10.23M | $9.04M | $5.13M | $4.94M | $5.99M | $5.73M | $4.08M | $3.81M | $3.12M | $2.44M | $838K | $36K |
| Deferred Income Tax | -$2.2M | -$106.76M | $0 | $0 | -$55.7M | -$54.04M | -$11.29M | -$3.56M | $1.89M | -$6.98M | $0 | -$42.29M | -$2.69M | -$22.39M | $3.5M | $10.74M | -$5.16M | -$5.5M | $1.89M | -$7.92M | $0 | -$4.11M | $0 | $0 |
| Stock-Based Compensation | $348.24M | $272.08M | $221.68M | $230.65M | $165.72M | $139.87M | $174.84M | $157.75M | $92.82M | $75.53M | $45.78M | $33.06M | $20.7M | $12.36M | $16.8M | $19.34M | $20.17M | $18.03M | $14.47M | $8.3M | $0 | $4.11M | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||||||||||||
| Accounts Receivable | -$359.96M | -$86.55M | -$87.94M | -$45.6M | -$101.8M | -$56.24M | -$24.24M | $15.24M | -$10.67M | -$15.04M | $31.64M | -$35.69M | -$4.14M | $1.36M | $12.65M | $0 | $0 | $843K | $0 | $0 | $243K | -$310K | $0 | $0 |
| Inventory | $8.47M | $13.59M | $18.37M | -$34.14M | -$26.41M | -$35.43M | -$32.41M | -$22.64M | $0 | $0 | $0 | $3.29M | $191K | -$1.81M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $75.07M | $91.09M | $80.84M | $191.77M | $88.24M | $117.38M | $36.61M | $15.48M | -$4.94M | $10.1M | $1.68M | $8.84M | $1.83M | -$1.74M | -$3.51M | -$3.18M | $9.9M | -$1.24M | -$264K | $2.09M | $0 | -$615K | $0 | $0 |
| Other Working Capital | -$168.36M | -$232.22M | -$509K | -$147.59M | -$122.85M | -$38.41M | $422.42M | $37.02M | $12.71M | $22.16M | $1.8M | -$5.84M | -$6M | -$6.78M | -$65.07M | -$76.38M | -$60.31M | $64.3M | $254.68M | -$4.74M | $16.51M | $4.41M | $2.91M | $2.65M |
| Total Working Capital Change | -$444.78M | -$214.08M | $10.76M | -$35.55M | -$162.82M | -$12.7M | $402.38M | $45.1M | -$2.9M | $17.22M | $35.12M | -$29.4M | -$8.12M | -$8.96M | -$55.93M | -$79.56M | -$50.41M | $63.9M | $254.42M | -$2.65M | $16.76M | $3.48M | $2.91M | $2.65M |
| Other Non-Cash Items | $253.42M | $261.94M | $257.9M | $350.32M | $216.37M | $95.75M | -$12.61M | -$6.84M | $2.91M | $1.51M | $984K | $221.46M | $449K | $364K | $1.08M | $3.71M | $4.86M | $9.59M | $7.12M | $8.43M | $6.55M | $7.16M | $8.46M | $172K |
| Net Cash from Operating | $524.08M | -$8.31M | $104.16M | -$541.27M | -$641.69M | -$614.96M | -$278.43M | -$562.62M | -$382.79M | -$307.7M | -$189.14M | -$165.64M | -$68.66M | -$115.61M | -$87.07M | -$84.34M | -$72.14M | $65.49M | $196.52M | -$24.63M | -$16.48M | -$19.57M | -$12.83M | -$1.28M |
| Investing Activities | ||||||||||||||||||||||||
| Capital Expenditures | -$58.7M | -$34.28M | -$62.21M | -$72.06M | -$76.37M | -$70.36M | -$140.16M | -$126.89M | -$104.21M | -$64.56M | -$12.95M | -$8.96M | -$4.01M | -$8.35M | -$1.29M | -$4.73M | -$4.95M | -$10.76M | -$7.79M | -$4.99M | -$1.95M | -$9.01M | -$3.12M | -$562K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$25M | $0 | $0 | -$81.96M | -$17.84M | -$10M | -$100K | $2.34M | $0 | $40.42M | $0 | -$121K | $0 |
| Purchases of Investments | -$1.36B | -$1.71B | -$1.82B | -$1.98B | -$1.66B | -$2.03B | -$2.08B | -$1.1B | -$903.46M | -$759.31M | -$1.03B | -$977.77M | -$364.31M | -$277.13M | -$293.12M | -$390.47M | -$481.34M | -$482.24M | -$554.39M | -$172.3M | -$70.88M | -$33.5M | $0 | $0 |
| Sales of Investments | $1.8B | $1.57B | $1.55B | $2.23B | $1.46B | $1.69B | $1.78B | $1.52B | $597.3M | $1.12B | $726.94M | $462.92M | $237.81M | $289.01M | $376.37M | $413.04M | $504.57M | $511.04M | $283.25M | $147.24M | $32.41M | $7.72M | $0 | $0 |
| Other Investing Activities | $57.63M | $57.76M | -$4.44M | -$13.19M | -$4.36M | -$31.2M | $23M | -$14.82M | $120M | -$150M | -$1.47M | $0 | $0 | -$162K | $81.96M | $17.84M | $6.15M | $0 | -$839K | $0 | -$40.42M | $0 | $0 | $0 |
| Net Cash from Investing | $436.33M | -$116.84M | -$336.35M | $169.35M | -$273.3M | -$435.52M | -$417.68M | $272.94M | -$290.36M | $142.59M | -$321.32M | -$548.81M | -$130.5M | $3.37M | $81.96M | $17.84M | $14.43M | $17.94M | -$277.43M | -$30.05M | -$40.42M | -$34.59M | -$3.24M | -$562K |
| Financing Activities | ||||||||||||||||||||||||
| Debt Repaid | $546.95M | - | - | -$254M | -$500M | -$200M | $30M | - | $120M | -$150M | - | - | - | - | - | - | - | - | - | -$1.74M | -$194K | -$5.34M | $1.1M | - |
| Common Stock Issuance | $250.03M | $302.95M | $147.46M | $259.36M | $246.27M | $99.5M | $781.9M | $68.94M | $1.16B | $14.3M | $585.42M | $723.04M | $173.57M | $86.8M | $738K | $993K | $3.51M | $9.91M | $61.01M | $164.89M | $52.42M | $45.31M | $27.48M | $17.34M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3.47M | -$257K | -$596K | -$378K | -$15.99M | -$1.39M | -$359K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$8.27M | -$8.79M | $24.67M | -$87.61M | $500.85M | $695.48M | $71.28M | $0 | $83.89M | $14.13M | $31.14M | $29.42M | $28.74M | $6.97M | $0 | $2.67M | $0 | $0 | $0 | $0 | $0 | $327K | -$2.67M | -$28K |
| Net Cash from Financing | -$305.19M | $294.16M | $172.13M | $425.75M | $1.25B | $994.98M | $823.18M | $65.47M | $1.12B | $177.83M | $616.18M | $736.47M | $200.93M | $93.41M | $738K | $3.66M | $3.51M | $3.15M | $58.63M | $166.63M | $52.62M | $50.98M | $23.71M | $17.32M |
| Forex Effect | $34.94M | -$15.24M | $6.39M | -$7.43M | -$9.02M | $4.92M | -$83K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$29K | -$121K | $53K | -$527K | $243K | -$229K | $267K | $76K | $1.84M |
| Net Change in Cash | $690.15M | $153.77M | -$53.67M | $46.4M | $323.11M | -$50.58M | $127M | -$224.2M | $451.74M | $12.72M | $105.72M | $22.01M | $1.76M | -$18.82M | -$4.37M | -$62.87M | -$54.32M | $86.64M | -$22.8M | $112.2M | -$4.51M | -$2.92M | $7.72M | $17.32M |
| Supplementary Data | ||||||||||||||||||||||||
| Operating Cash Flow | $524.08M | -$8.31M | $104.16M | -$541.27M | -$641.69M | -$614.96M | -$278.43M | -$562.62M | -$382.79M | -$307.7M | -$189.14M | -$165.64M | -$68.66M | -$115.61M | -$87.07M | -$84.34M | -$72.14M | $65.49M | $196.52M | -$24.63M | -$16.48M | -$19.57M | -$12.83M | -$1.28M |
| Capital Expenditure | -$58.7M | -$34.28M | -$62.21M | -$72.06M | -$76.37M | -$70.36M | -$140.16M | -$126.89M | -$104.21M | -$64.56M | -$12.95M | -$8.96M | -$4.01M | -$8.35M | -$1.29M | -$4.73M | -$4.95M | -$10.76M | -$7.79M | -$4.99M | -$1.95M | -$9.01M | -$3.12M | -$562K |
| Free Cash Flow | $465.38M | -$42.59M | $41.95M | -$613.33M | -$718.07M | -$685.32M | -$418.58M | -$689.5M | -$487M | -$372.26M | -$202.09M | -$174.6M | -$72.66M | -$123.96M | -$88.36M | -$89.07M | -$77.09M | $54.73M | $188.73M | -$29.62M | -$18.43M | -$28.58M | -$15.95M | -$1.84M |
| Cash at Beginning | $968.65M | $814.88M | $868.56M | $822.15M | $499.05M | $549.63M | $422.63M | $646.83M | $193.62M | $180.9M | $75.18M | $53.17M | $51.41M | $70.23M | $74.6M | $137.47M | $191.79M | $105.16M | $127.95M | $15.76M | $20.27M | $23.19M | $15.48M | -$1.84M |
| Cash at End | $1.66B | $968.65M | $814.88M | $868.56M | $822.15M | $499.05M | $549.63M | $422.63M | $645.36M | $193.62M | $180.9M | $75.18M | $53.17M | $51.41M | $70.23M | $74.6M | $137.47M | $191.79M | $105.16M | $127.95M | $15.76M | $20.27M | $23.19M | $15.48M |